DISCOVER study publications update

Publication milestones for DISCOVER

 

The DISCOVER methods and rationale manuscript has been accepted for publication, and first baseline results will be presented at the 77th Scientific Sessions of the American Diabetes Association.

 

DISCOVER study publications update

DISCOVER study publications update

 

With recruitment of patients to the DISCOVER study successfully completed, ambitious plans for the publication of baseline data are underway.

 

DISCOVER Scientific Bulletin to share news and successes

DISCOVER Scientific Bulletin to share news and successes

 

All the latest exciting updates on the progress of the global DISCOVER study will soon be made available to investigators in a new Scientific Bulletin.

 

The DISCOVER study

 

DISCOVER is a global, prospective, observational study of patients with type 2 diabetes who are starting second-line glucose-lowering therapy. The study has enrolled over 15 000 patients in 38 countries across six continents, and will provide a comprehensive and contemporary picture of treatment patterns and outcomes in patients with type 2 diabetes worldwide.

 

Type 2 diabetes and real world evidence

 

The DISCOVER study is designed to generate real world evidence (RWE) about people living with type 2 diabetes across the globe. RWE is key to understanding more about type 2 diabetes and how it is managed in day-to-day clinical practice, and therefore contributes to improved disease management.

 

DISCOVER publications

 

The DISCOVER study will provide unprecedented global insights into the treatment of type 2 diabetes. The DISCOVER Scientific Committee is planning a series of abstracts, posters, presentations and journal articles about the DISCOVER study design and results at global, regional and local levels.

 

Retention of patients in DISCOVER

Retention of patients in DISCOVER

 

Dr Márcio Antonio Pereira stresses the importance of patient participation in the study in order to improve quality of life.

 

Thank you from the DISCOVER team

Thank you from the DISCOVER team

 

The DISCOVER team would like to thank all of those involved in DISCOVER for their commitment and hard work in recruiting patients into the study.

 

The DISCOVER study

The DISCOVER study

 

DISCOVER is a global, prospective, observational study of patients with type 2 diabetes who are starting second-line glucose-lowering therapy. The study has enrolled over 15 000 patients in 38 countries across six continents, and will provide a comprehensive and contemporary picture of treatment patterns and outcomes in patients with type 2 diabetes worldwide.

 
 

Type2 diabetes and real world evidence

Type 2 diabetes and real world evidence

The DISCOVER study is designed to generate real world evidence (RWE) about people living with type 2 diabetes across the globe. RWE is key to understanding more about type 2 diabetes and how it is managed in day-to-day clinical practice, and therefore contributes to improved disease management.

 

DISCOVER publications

DISCOVER publications

 

The DISCOVER study will provide unprecedented global insights into the treatment of type 2 diabetes. The DISCOVER Scientific Committee is planning a series of abstracts, posters, presentations and journal articles about the DISCOVER study design and results at global, regional and local levels.